Impacts of dialysis adequacy and intradialytic hypotension on changes in dialysis recovery time

摘要

Dialysis recovery time (DRT) surveys capture the perceived time after HD to return to performing regular activities. Prior studies suggest the majority of HD patients report a DRT ?2?h. However, the profiles of and modifiable dialysis practices associated with changes in DRT relative to the start of dialysis are unknown. We hypothesized hemodialysis (HD) dose and rates of intradialytic hypotension (IDH) would associate with changes in DRT in the first years after initiating dialysis. We analyzed data from adult HD patients who responded to a DRT survey ≤180?days from first date of dialysis (FDD) during 2014 to 2017. DRT survey was administered with annual KDQOL survey. DRT survey asks: “How long does it take you to be able to return to your normal activities after your dialysis treatment?” Answers are: 4?h. An adjusted logistic regression model computed odds ratio for a change to a longer DRT (increase above DRT ?2?h) in reference to a change to a shorter DRT (decrease below DRT 4?h). Changes in DRT were calculated from incident (≤180?days FDD) to first prevalent (?365-to-?≤?545?days FDD) and second prevalent (?730-to-?≤?910?days FDD) years. Among 98,616 incident HD patients (age 62.6?±?14.4?years, 57.8% male) who responded to DRT survey, a higher spKt/V in the incident period was associated with 13.5% (OR?=?0.865; 95%CI 0.801-to-0.935) lower risk of a change to a longer DRT in the first-prevalent year. A higher number of HD treatments with IDH episodes per month in the incident period was associated with a 0.8% (OR?=?1.008; 95%CI 1.001-to-1.015) and 1.6% (OR?=?1.016; 95%CI 1.006-to-1.027) higher probability of a change to a longer DRT in the first- and second-prevalent years, respectively. Consistently, an increased in incidence of IDH episodes/months was associated to a change to a longer DRT over time. Incident patients who had higher spKt/V and less sessions with IDH episodes had a lower likelihood of changing to a longer DRT in first year of HD. Dose optimization strategies with cardiac stability in fluid removal should be tested.